RMC No. 47-2022: VAT-Exempt COVID-19 Medicines Under the CREATE Act and FDA-Endorsed Updates for Philippine Taxpayers

RMC No. 47-2022 publishes FDA-endorsed updates adding certain COVID-19 treatment medicines to the CREATE Act VAT-exempt medicines list. Businesses selling, purchasing, prescribing, distributing, or accounting for COVID-19 treatment medicines must check whether the medicine is covered by the FDA-endorsed updates to the list of VAT-exempt medicines under the CREATE Act, because covered medicines should be […]